首頁 › 尿路上皮（移行細胞）癌 › 德克薩斯州 › San Antonio
San Antonio, TX 的 尿路上皮（移行細胞）癌 臨床試驗
11 項針對 尿路上皮（移行細胞）癌 的研究正在 San Antonio（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
DBC-664 in Adult Patients With Solid Tumors
招募中1 期
- START San Antonio, San Antonio
A Study of GEN1106 in Participants With Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics, San Antonio
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- START - San Antonio, San Antonio
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
招募中3 期
- USA Operation d/b/a US Clinical Trials, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
招募中1 期
- START San Antonio, San Antonio
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
招募中1 期
- NEXT Oncology, San Antonio, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
招募中1/2 期
- Clinical Trial Site, San Antonio
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
招募中1/2 期
- Next Oncology-Oncology, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, San Antonio
其他城市的 尿路上皮（移行細胞）癌 試驗
- Nashville, TN23 項研究
- New York City, NY22 項研究
- Houston, TX19 項研究
- Dallas, TX18 項研究
- Edison, NJ18 項研究
- Los Angeles, CA17 項研究
- Queens, NY15 項研究
- Chicago, IL14 項研究
- Arlington, VA12 項研究
- Boston, MA11 項研究
- Austin, TX10 項研究
- Orange, CA10 項研究
San Antonio 的其他研究
- 非小細胞肺癌59 項研究
- 乳癌47 項研究
- 大腸直腸癌46 項研究
- 轉移性癌症44 項研究
- 癌症（所有類型）41 項研究
- 肥胖症40 項研究
- 第二型糖尿病37 項研究
- 過重34 項研究
- 卵巢癌31 項研究
- 胰臟癌31 項研究
- 前列腺癌28 項研究
- 子宮內膜癌27 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。